BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2006
View Archived Issues
Topical phenytoin administration may be useful for nonhealing corneal ulcers
Read More
Data on new cancer therapeutics presented at EORTC-NCI-AACR
Read More
Emergence of X4 phenotype with maraviroc investigated in HIV patients
Read More
Drug-drug interactions, other data on etravirine reported
Read More
West Nile virus vaccine candidates show promise
Read More
ALK-Abello and Menarini sign Grazax agreement
Read More
Hookworm vaccine, treatment evaluated in clinical studies
Read More
IRB approval for phase II study of DCVax-Brain in GBM
Read More
Elixir raises proceeds to support pipeline development
Read More
Norwood Immunology shareholders approve Virosome Biologicals acquisition
Read More
Positive data for Multiferon in rabbitpox virus study
Read More
Sinclair signs agreement to acquire novel anticaries peptide p1025
Read More
Sulforaphane investigated for chemoprevention
Read More
Genzyme acquires option for NsGene's neurotrophic factor NsG-33
Read More
SB-509 begins phase II study for diabetic neuropathy
Read More
Cetrorelix set to begin phase III for BPH
Read More
Abuse-resistant PTI-202 safe and well tolerated in phase I study
Read More
Genasense studied together with Abraxane and Temodar in advanced melanoma
Read More
Atu-027 RNAi more effective in prevention of metastases than gemcitabine
Read More
Boehringer Ingelheim ensures access to Viramune in developing countries
Read More
M-Vax phase III trial in metastatic melanoma cleared to begin
Read More
Interim results suggest antileukemic activity of sapacitabine
Read More
Japanese approval sought for nateglinide in combination with insulin sensitizer
Read More
Sprycel approved in E.U.
Read More
Recent patents divulge novel analgesic agents
Read More
Novel agents for treating renal and urological disorders disclosed in recent patents
Read More